Last reviewed · How we verify
ALIZAPRIDE
ALIZAPRIDE is a alizapride drug. It is currently FDA-approved for Nausea and vomiting, Postoperative nausea and vomiting.
Alizapride is a small molecule dopamine D2 receptor antagonist. It has been studied in clinical trials for conditions such as chemotherapy-induced nausea and vomiting, nausea, and vomiting, including in patients with early breast cancer.
At a glance
| Generic name | ALIZAPRIDE |
|---|---|
| Drug class | alizapride |
| Target | D(2) dopamine receptor |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Nausea and vomiting
- Postoperative nausea and vomiting
Common side effects
Key clinical trials
- Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer. (PHASE4)
- A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) (PHASE4)
- Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ALIZAPRIDE CI brief — competitive landscape report
- ALIZAPRIDE updates RSS · CI watch RSS
Frequently asked questions about ALIZAPRIDE
What is ALIZAPRIDE?
What is ALIZAPRIDE used for?
What drug class is ALIZAPRIDE in?
What development phase is ALIZAPRIDE in?
What does ALIZAPRIDE target?
Related
- Drug class: All alizapride drugs
- Target: All drugs targeting D(2) dopamine receptor
- Therapeutic area: All drugs in Other
- Indication: Drugs for Nausea and vomiting
- Indication: Drugs for Postoperative nausea and vomiting
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing